AR100745A1 - Nanopartículas de quitosano cargadas con antígeno para inmunoterapia - Google Patents
Nanopartículas de quitosano cargadas con antígeno para inmunoterapiaInfo
- Publication number
- AR100745A1 AR100745A1 ARP150101789A ARP150101789A AR100745A1 AR 100745 A1 AR100745 A1 AR 100745A1 AR P150101789 A ARP150101789 A AR P150101789A AR P150101789 A ARP150101789 A AR P150101789A AR 100745 A1 AR100745 A1 AR 100745A1
- Authority
- AR
- Argentina
- Prior art keywords
- antigen
- nanoparticles
- quitosane
- immunotherapy
- nanoparticles loaded
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14001974 | 2014-06-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR100745A1 true AR100745A1 (es) | 2016-10-26 |
Family
ID=50897334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150101789A AR100745A1 (es) | 2014-06-06 | 2015-06-05 | Nanopartículas de quitosano cargadas con antígeno para inmunoterapia |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10369217B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3151856B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6730937B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN106456746B (cg-RX-API-DMAC7.html) |
| AR (1) | AR100745A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015271295B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2951063C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2754507T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL249357B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015185180A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3698773A1 (en) | 2019-02-21 | 2020-08-26 | Università degli Studi di Parma | Composition and manufacturing of powders containing nanoadjuvants for mucosal vaccination |
| CN110974805A (zh) * | 2019-12-23 | 2020-04-10 | 中国科学院海洋研究所 | 具有增强抗原提呈细胞提呈抗原作用的壳聚糖衍生物纳米粒及制备 |
| GB202018665D0 (en) * | 2020-11-26 | 2021-01-13 | Provost Fellows And Scholars Of Trinity College Dublin | Immunotherapy for cancer |
| WO2023168541A1 (en) * | 2022-03-09 | 2023-09-14 | Shenzhen Genius Biotech Service Co., Ltd. | Chitosan nanoparticles (cnps) and preparation method thereof |
| WO2024083221A1 (zh) * | 2022-10-21 | 2024-04-25 | 北京安必奇生物科技有限公司 | 一种黏膜给药制剂及其制备方法和应用 |
| CN119506406A (zh) * | 2023-08-24 | 2025-02-25 | 康希诺生物股份公司 | 一种表征吸入疫苗性能的方法 |
| WO2025209535A1 (en) * | 2024-04-03 | 2025-10-09 | Suzhou Xinxin Biopharma Co., Ltd | Compositions and associated methods for chitosan-based nano-carriers for therapeutic agents and their applications |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100638041B1 (ko) * | 2003-12-24 | 2006-10-23 | 주식회사 삼양사 | 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법 |
| US8137697B1 (en) * | 2004-10-05 | 2012-03-20 | Gp Medical, Inc. | Nanoparticles for protein/peptide delivery and delivery means thereof |
| ES2259914B1 (es) * | 2005-03-14 | 2007-06-16 | Advanced In Vitro Cell Technologies, S.L. | Nanoparticulas de quitosano y polietilenglicol como sistema de administracion de moleculas biologicamente activas. |
| EP2397123A1 (en) * | 2006-07-07 | 2011-12-21 | Aarhus Universitet | Nanoparticles for nucleic acid delivery |
| US20100150960A1 (en) * | 2006-09-22 | 2010-06-17 | The United States Of America, As Represented By The Secretary,Department Of Health And Human Servi | Compositions and methods for chitosan enhanced immune response |
| US20110189299A1 (en) * | 2008-07-01 | 2011-08-04 | Nitto Denko Corporation | Pharmaceutical composition containing surface-coated microparticles |
| CN104703584B (zh) * | 2012-02-28 | 2019-05-31 | 艾塞尤提卡控股公司 | 可吸入药物组合物 |
-
2015
- 2015-05-12 WO PCT/EP2015/000974 patent/WO2015185180A1/en not_active Ceased
- 2015-05-12 CN CN201580030088.4A patent/CN106456746B/zh active Active
- 2015-05-12 CA CA2951063A patent/CA2951063C/en active Active
- 2015-05-12 ES ES15722448T patent/ES2754507T3/es active Active
- 2015-05-12 US US15/316,709 patent/US10369217B2/en active Active
- 2015-05-12 EP EP15722448.6A patent/EP3151856B1/en active Active
- 2015-05-12 JP JP2016571251A patent/JP6730937B2/ja active Active
- 2015-05-12 AU AU2015271295A patent/AU2015271295B2/en active Active
- 2015-06-05 AR ARP150101789A patent/AR100745A1/es unknown
-
2016
- 2016-12-04 IL IL249357A patent/IL249357B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| JP6730937B2 (ja) | 2020-07-29 |
| AU2015271295A1 (en) | 2017-01-19 |
| IL249357A0 (en) | 2017-02-28 |
| JP2017516834A (ja) | 2017-06-22 |
| EP3151856B1 (en) | 2019-08-07 |
| ES2754507T3 (es) | 2020-04-17 |
| CA2951063A1 (en) | 2015-12-10 |
| IL249357B (en) | 2021-01-31 |
| CA2951063C (en) | 2022-10-04 |
| US20170143822A1 (en) | 2017-05-25 |
| CN106456746A (zh) | 2017-02-22 |
| EP3151856A1 (en) | 2017-04-12 |
| CN106456746B (zh) | 2021-03-26 |
| WO2015185180A1 (en) | 2015-12-10 |
| AU2015271295B2 (en) | 2020-04-16 |
| US10369217B2 (en) | 2019-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR100745A1 (es) | Nanopartículas de quitosano cargadas con antígeno para inmunoterapia | |
| TR201908550T4 (tr) | Profilaktik veya terapötik uygulamalar için lipozomal sferik nükleik asitler tarafından immün modülatörlerin çok değerlikli teslimi. | |
| CY1124979T1 (el) | Κατασκευασματα πρωτεϊνης uspa2 και χρησεις αυτων | |
| EA202090919A1 (ru) | Липидные наночастицы для доставки модифицированной рнк, кодирующей полипептид vegf-a | |
| BR112017008165A2 (pt) | anticorpos de domínio único direcionados contra antígenos intracelulares | |
| MX2017005344A (es) | Composiciones y metodos para reforzar la eficacia de inmunoterapia celular adoptiva. | |
| CL2018000232A1 (es) | Mezcla de péptidos (divisional solicitud 201601405) | |
| EA201691478A1 (ru) | Новый полисахарид и его применения | |
| WO2014113490A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
| EA201790248A1 (ru) | Композиции носитель-антитело и способы их получения и применения | |
| EA201692425A1 (ru) | Модифицированные биополимеры и способы их получения и использования | |
| ES2721309T3 (es) | Composición para preparar tagatosa y método para preparar tagatosa a partir de fructosa | |
| EA201790294A1 (ru) | Средства на основе флагеллина и применения, включающие эффективную вакцинацию | |
| EA201790265A1 (ru) | Способы получения тромбоцит-содержащих продуктов | |
| MX386234B (es) | Vacuna para la malaria. | |
| PH12018000197A1 (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
| EA201891124A3 (ru) | Новые мукозные адъюванты и системы доставки | |
| MX387421B (es) | Producción de virus en huevos aviares. | |
| MX377258B (es) | Composiciones de vectores poxvirus y su uso para inducir una respuesta inmunitaria. | |
| MD20150109A2 (ro) | Construcţii proteice mitocondriale şi utilizările acestora | |
| EP3939604A3 (en) | Influenza hemagglutinin protein vaccines | |
| TN2014000518A1 (en) | Reassortant btv and ahsv vaccines | |
| MX385886B (es) | Macromoleculas estrellas compatibles con tensoactivos. | |
| BR112016012838A2 (pt) | Composição para a administração oral de um agente bioativo incluindo partículas que compreendem um agente bioativo e um polímero mucoadesivo em uma solução aquosa, e, método de preparação da composição | |
| MX2015013304A (es) | Vacunas de nucleoproteina de la influenza. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |